أخبار الذكاء الاصطناعي
GPT-5.6: Frontier intelligence that scales with your ambition
More intelligence from every token, stronger performance per dollar, and more capability on demand for your hardest work.
اقرأ المزيد ←
الذكاء الاصطناعي
NHS AI blood test could reduce invasive womb cancer checks
Several NHS hospitals are preparing to use an AI-powered blood test to help assess women referred for possible womb cancer before invasive checks are carried out. According to The Guardian, around 90,000 postmenopausal women in England are referred by GPs each year for checks after experiencing heavy bleeding. About 10,000 women are diagnosed with womb […] The post NHS AI blood test could reduce invasive womb cancer checks appeared first on AI News .
اقرأ المزيد ←Our approach to government and national security partnerships
Learn how OpenAI approaches government and national security partnerships, with principles for responsible AI use, democratic accountability, and public safety.
اقرأ المزيد ←Separating signal from noise in coding evaluations
A new analysis from OpenAI reveals issues in SWE-Bench Pro, a popular coding benchmark, raising concerns about reliability and accuracy in evaluating AI models.
اقرأ المزيد ←Helping K–12 educators build practical AI skills
OpenAI Academy and the Walton Family Foundation are bringing hands-on AI Skills Jams to help K–12 educators build practical AI skills for the classroom.
اقرأ المزيد ←Introducing GPT-Live
A new generation of voice models for natural human-AI interaction, now powering ChatGPT Voice.
اقرأ المزيد ←
الذكاء الاصطناعي
Insilico Medicine advances AI drug for IPF to Phase III trials
Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic pulmonary fibrosis (IPF). This progression supplies the computational drug discovery sector with empirical test cases, advancing an AI medicine past early safety evaluations into late-stage efficacy validation. IPF destroys respiratory capacity through severe lung tissue scarring. Patients […] The post Insilico Medicine advances AI drug for IPF to Phase III trials appeared first on AI News .
اقرأ المزيد ←
الذكاء الاصطناعي
Companies traded people for tokens. The returns haven’t shown up
Jensen Huang has a test for whether an engineer is worth keeping, and it comes with a token budget attached. On the All-In Podcast at the close of GTC 2026, the Nvidia chief executive said that if a US$500,000 engineer’s annual AI token consumption came in under US$250,000, half their salary, “I am going to be deeply alarmed.” Nvidia, […] The post Companies traded people for tokens. The returns haven’t shown up appeared first on AI News .
اقرأ المزيد ←
الذكاء الاصطناعي
L’Oreal, Mondelez, and Nestle use AI to speed product development
L’Oreal is using AI to shorten product development timelines and identify new uses for ingredients already present in its portfolio. The French cosmetics group has applied AI in its laboratories for the past four years, with Fabrice Megarbane, president of L’Oreal’s consumer products division, telling Reuters that the technology helps the company predict how molecules […] The post L’Oreal, Mondelez, and Nestle use AI to speed product development appeared first on AI News .
اقرأ المزيد ←Australian Payments Plus moves faster with ChatGPT and Codex
See how Australian Payments Plus uses ChatGPT Enterprise and Codex to move faster through payments complexity. AP+ saves time, improves quality, and keeps human judgment central.
اقرأ المزيد ←
الذكاء الاصطناعي
China’s AI companion rules: what Beijing is really going after
An AI companion sounds dystopian, but it has become a common thread in the wider conversation about the perils of generative AI. What it refers to is essentially a conversational agent built to sustain an ongoing, personal relationship with a user, with the memory and steady persona that keep it consistent from one session to […] The post China’s AI companion rules: what Beijing is really going after appeared first on AI News .
اقرأ المزيد ←